Gamida Cell Stock (NASDAQ: GMDA) stock price, news, charts, stock research, profile.
|Vol / Avg.117.852K / 1.706M||Mkt Cap40.680M|
|Day Range- - -||52 Wk Range0.218 - 2.510|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-15||Piper Sandler||Edward Tenthoff||Maintains||OverweightOverweight||Lowers||5.00||2.00|
|2023-11-15||HC Wainwright & Co.||Vernon Bernardino||Maintains||BuyBuy||Lowers||11.00||5.00|
|2023-09-28||JMP Securities||Jason Butler||Reiterates||Market OutperformMarket Outperform||Maintains||-||6.00|
|2023-08-16||HC Wainwright & Co.||Vernon Bernardino||Reiterates||BuyBuy||Maintains||-||11.00|
You can purchase shares of Gamida Cell (NASDAQ: GMDA) through any online brokerage.
There are no as such competitors for Gamida Cell.
The latest price target for Gamida Cell (NASDAQ: GMDA) was reported by Piper Sandler on Wednesday, November 15, 2023. The analyst firm set a price target for 2.00 expecting GMDA to rise to within 12 months (a possible 552.10% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Gamida Cell (NASDAQ: GMDA) is $0.3067 last updated Today at November 30, 2023 at 12:01 PM UTC.
There is no dividend information for Gamida Cell.
Gamida Cell’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Gamida Cell.
Gamida Cell is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.